Antonio Villaverde Selected Research

Antonio Villaverde Research Topics

Disease

42	Neoplasms (Cancer) 12/2022 - 01/2009
9	Colorectal Neoplasms (Colorectal Cancer) 06/2021 - 01/2012
5	Neoplasm Metastasis (Metastasis) 12/2022 - 01/2019
5	Lymphoma (Lymphomas) 06/2022 - 01/2020
5	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 01/2018
5	Infections 11/2021 - 05/2003
3	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 06/2022 - 01/2020
3	Squamous Cell Carcinoma of Head and Neck 05/2022 - 02/2022
3	Fabry Disease (Fabry's Disease) 01/2021 - 04/2016
2	Neurodegenerative Diseases (Neurodegenerative Disease) 02/2021 - 04/2007
2	Amyloidosis 02/2021 - 04/2007
1	Diphtheria 02/2022
1	Prion Diseases (Transmissible Spongiform Encephalopathies) 02/2021
1	Parkinson Disease (Parkinson's Disease) 02/2021
1	Multiple System Atrophy 02/2021
1	Communicable Diseases (Infectious Diseases) 11/2020
1	Triple Negative Breast Neoplasms 02/2020
1	Residual Neoplasm 01/2020
1	Breast Neoplasms (Breast Cancer) 09/2019
1	Chronic Disease (Chronic Diseases) 09/2019
1	Virus Diseases (Viral Diseases) 01/2018
1	Hemorrhagic Septicemia (Haemorrhagic Septicemia) 01/2018
1	Necrosis 01/2018
1	Leukemia 01/2018
1	Bacterial Infections (Bacterial Infection) 01/2017
1	Central Nervous System Diseases (CNS Diseases) 03/2015
1	Sarcoma (Soft Tissue Sarcoma) 02/2015
1	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2014

Drug/Important Bio-Agent (IBA)

36	Proteins (Proteins, Gene)FDA Link 05/2022 - 04/2007
23	Pharmaceutical PreparationsIBA 12/2022 - 01/2009
11	Peptides (Polypeptides)IBA 05/2022 - 04/2002
8	LigandsIBA 02/2022 - 10/2016
6	NanoconjugatesIBA 01/2022 - 10/2016
4	Chemokine ReceptorsIBA 05/2022 - 01/2018
4	EnzymesIBA 01/2021 - 04/2002
4	Drug CarriersIBA 02/2020 - 10/2016
3	Diphtheria ToxinIBA 06/2022 - 10/2021
3	Antineoplastic Agents (Antineoplastics)IBA 10/2021 - 01/2018
3	CXCR4 Receptors (CXCR4 Receptor)IBA 01/2020 - 01/2012
3	Recombinant ProteinsIBA 01/2018 - 05/2003
2	Cytotoxins (Cytolysins)IBA 12/2022 - 05/2022
2	Bacterial ToxinsIBA 05/2022 - 01/2020
2	ExotoxinsIBA 02/2022 - 01/2020
2	Cytokine Receptors (Cytokine Receptor)IBA 01/2022 - 11/2021
2	monomethyl auristatin EIBA 01/2022 - 01/2022
2	auristatinIBA 01/2021 - 01/2020
2	GalactosidasesIBA 10/2016 - 04/2016
1	nidogen (entactin)IBA 04/2022
1	Staphylococcal Protein A (Protein A)IBA 04/2022
1	Propidium (Propidium Iodide)IBA 02/2022
1	Caspase 3 (Caspase-3)IBA 02/2022
1	T22 peptideIBA 02/2022
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 02/2022
1	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2022
1	ProdrugsIBA 01/2022
1	Immunoconjugates (Immunoconjugate)IBA 01/2022
1	Membrane Proteins (Integral Membrane Proteins)IBA 06/2021
1	Human Serum Albumin FDA LinkGeneric 06/2021
1	Floxuridine (FUdR)FDA LinkGeneric 01/2021
1	Drug CombinationsIBA 01/2021
1	Fluorescent Dyes (Fluorescent Probes)IBA 10/2020
1	nucleolin binding peptideIBA 02/2020
1	NucleolinIBA 02/2020
1	Cell Surface ReceptorsIBA 02/2020
1	Pseudomonas exotoxin PE24IBA 02/2020
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2020
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2020
1	plerixafor FDA Link 01/2020
1	Prednisone (Sone)FDA LinkGeneric 01/2020
1	Rituximab (Mabthera)FDA Link 01/2020
1	Vincristine (Oncovin)FDA LinkGeneric 01/2020
1	Immunotoxins (Immunotoxin)IBA 01/2020
1	OligonucleotidesIBA 03/2019
1	Dyneins (Dynein)IBA 01/2018
1	A-Form DNA (A-DNA)IBA 01/2018
1	RicinIBA 01/2018
1	Glycoproteins (Glycoprotein)IBA 01/2018
1	Cell-Penetrating PeptidesIBA 01/2018
1	Arginine (L-Arginine)FDA Link 01/2018
1	Therapeutic UsesIBA 01/2018
1	Viral ProteinsIBA 01/2018
1	Green Fluorescent ProteinsIBA 01/2017
1	Antimicrobial Cationic PeptidesIBA 01/2017
1	PolyelectrolytesIBA 10/2016
1	ChitosanIBA 10/2016
1	Carrier Proteins (Binding Protein)IBA 10/2016
1	GlycosphingolipidsIBA 04/2016
1	Biological ProductsIBA 06/2015
1	Angiopoietin-2IBA 02/2015
1	IntegrinsIBA 02/2015
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2015
1	CXC ChemokinesIBA 02/2015
1	Valine (L-Valine)FDA Link 02/2015
1	Codon (Codons)IBA 02/2015
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 10/2013

Therapy/Procedure

21	Therapeutics 06/2022 - 01/2009
4	Drug Therapy (Chemotherapy) 10/2021 - 01/2020
1	Aftercare (After-Treatment) 02/2022
1	Intravenous Administration 01/2020
1	Intravenous Injections 01/2020